Carrie Arnold is a Virginia-based freelance science journalist who covers many aspects of the living world. She’s a contributing editor at NOVA Next, and has also written for Mosaic, National Geographic, Aeon, Nautilus, Scientific American and Women’s Health. She is also the author of “Decoding Anorexia: How Breakthroughs in Science Offer Hope for Eating Disorders.”
Carrie Arnold
From this contributor
Weighing up autism’s obesity crisis
Autism’s underlying biology, associated behaviors and treatments can all put people on the spectrum at serious risk for obesity.
Rare form of autism shows unique pattern of regression
More than 40 percent of children with Phelan-McDermid syndrome lose skills they once had, beginning, on average, at age 6.
Rare form of autism shows unique pattern of regression
The innovators: How families launch their own autism studies
Some parents are starting ‘N-of-1’ studies for autism, but their efforts don’t always get taken seriously.
The innovators: How families launch their own autism studies
The invisible link between autism and anorexia
Autism and anorexia may seem to have nothing in common, but below the surface, the two conditions are startlingly similar—and sometimes affect the same person.
The invisible link between autism and anorexia
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.